Skip to main content
SpringerLink
Log in

The Potential Role of TNF-α (rs361525 and rs1800629) in Hepatocellular Carcinoma: Multivariate Analysis (Meta-Analysis)

  • Original Research
  • Published:
Journal of Gastrointestinal Cancer Aims and scope Submit manuscript

Abstract

Purpose

Tumor necrosis factor-α has been suggested to play a crucial role in the development andprogression of hepatocellular carcinoma (HCC). Previous reports have indicated that rs361525 and rs1800629 might be risk factors for various cancers. Increasing studies have been conducted on the association of these two SNPs with HCC risk but the results remain inconclusive.

Methods

In order to detect association between TNF- α and HCC, a meta-analysis was performed. Five studies with 541 cases and 795 controls were used for rs361525, while six studies including 925 cases and 1307 controls were collected for investigating rs1800629. The grouping of countries from data were obtained was done by Principal Coordinate Analysis plot (PCA). Moreover, association between geographical area and grouping of genotypes was determined by Canonical Correspondence Analysis (CCA).

Results

Our meta-analysis showed that rs361525 and rs1800629 were not significantly associated with the risk of HCC. CCA analysis illustrated that there was not any correlation between genotype distribution and geographical distance for rs1800629 but there was significant correlation between genotype distribution and geographical features for rs361525. PCA analysis for both SNPs showed India and Korea were placed near each other and also China and Brazil were in same part of PCA plot.

Conclusion

To sum up, this meta-analysis suggests that the rs361525 and rs1800629 are not associated with HCC development while geographical distance effect on rs361525 genetic inheritance but not effect on rs1800629. However, it is necessary to conduct further studies with larger sample. Moreover, gene-gene and gene-environment interactions should also be considered.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5

Similar content being viewed by others

References

  1. Shin SP, Kim NK, Kim JH, Lee JH, Kim JO, Cho SH, et al. Association between hepatocellular carcinoma and tumor necrosis factor alpha polymorphisms in South Korea. World J Gastroenterol. 2015;21(46):13064.

    Article  CAS  Google Scholar 

  2. Siegel RL, Miller KD, Jemal A. Cancer statistics, 2015. CA Cancer J Clin. 2015;65(1):5–29.

    Article  Google Scholar 

  3. Ploss A, Dubuisson J. New advances in the molecular biology of hepatitis C virus infection: towards the identification of new treatment targets. Gut. 2012;61(Suppl 1):i25–35.

    Article  CAS  Google Scholar 

  4. Arzumanyan A, Reis HM, Feitelson MA. Pathogenic mechanisms in HBV-and HCV-associated hepatocellular carcinoma. Nat Rev Cancer. 2013;13(2):123–35.

    Article  CAS  Google Scholar 

  5. Mimi CY, Yuan J-M. Environmental factors and risk for hepatocellular carcinoma. Gastroenterology. 2004;127(5):S72–8.

    Article  Google Scholar 

  6. Zani C, Gelatti U, Donato F, Capelli M, Portolani N, Bergonzi R, et al. Polychlorinated biphenyls in serum, liver and adipose tissue of subjects with hepatocellular carcinoma living in a highly polluted area. Chemosphere. 2013;91(2):194–9.

    Article  CAS  Google Scholar 

  7. Balkwill F. TNF-α in promotion and progression of cancer. Cancer Metastasis Rev. 2006;25(3):409–16.

    Article  CAS  Google Scholar 

  8. Kushibiki S. Tumor necrosis factor-α-induced inflammatory responses in cattle. Anim Sci J. 2011;82(4):504–11.

    Article  Google Scholar 

  9. Lejeune FJ, Rüegg C, Liénard D. Clinical applications of TNF-α in cancer. Curr Opin Immunol. 1998;10(5):573–80.

    Article  CAS  Google Scholar 

  10. Balkwill F. Tumor necrosis factor or tumor promoting factor? Cytokine Growth Factor Rev. 2002;13(2):135–41.

    Article  CAS  Google Scholar 

  11. Wilson A, De Vries N, Fd P, Di Giovine F, Van der Putte L, Duff G. An allelic polymorphism within the human tumor necrosis factor alpha promoter region is strongly associated with HLA A1, B8, and DR3 alleles. J Exp Med. 1993;177(2):557–60.

    Article  CAS  Google Scholar 

  12. Huizinga TW, Westendorp RG, Bollen EL, Keijsers V, Brinkman BM, Langermans JA, et al. TNF-α promoter polymorphisms, production and susceptibility to multiple sclerosis in different groups of patients. J Neuroimmunol. 1997;72(2):149–53.

    Article  CAS  Google Scholar 

  13. Hajeer AH, Hutchinson IV. TNF-α gene polymorphism: clinical and biological implications. Microsc Res Tech. 2000;50(3):216–28.

    Article  CAS  Google Scholar 

  14. Bayley J-P, de Rooij H, van Den Elsen PJ, Huizinga TW, Verweij CL. Functional analysis of linker-scan mutants spanning the− 376,− 308,− 244, and− 238 polymorphic sites of the TNF-α promoter. Cytokine. 2001;14(6):316–23.

    Article  CAS  Google Scholar 

  15. Scardapane A, Breda L, Lucantoni M, Chiarelli F. TNF-α polymorphisms in juvenile idiopathic arthritis: which potential clinical implications? Int J Rheumatol. 2012;2012:1–16.

    Article  Google Scholar 

  16. Kroeger KM, Carville KS, Abraham LJ. The− 308 tumor necrosis factor-α promoter polymorphism effects transcription. Mol Immunol. 1997;34(5):391–9.

    Article  CAS  Google Scholar 

  17. Wilson A, Di Giovine F, Blakemore A, Duff G. Single base polymorphism in the human tumour necrosis factor alpha (TNFα) gene detectable by Ncol restriction of PCR product. Hum Mol Genet. 1992;1(5):353.

    Article  CAS  Google Scholar 

  18. Huang H, Xie J-S, Huang Z-S, Zhao Q. The relationship of polymorphism of tumor necrosis factor-α gene promoter-238G/A with primary hepatic carcinoma in patients. Prog Anat Sci. 2007;13:11–3.

  19. Tian X, Ma P, Sui C, Li Y, Fu L, Jiang T, et al. Comprehensive assessment of the association between tumor necrosis factor alpha G238A polymorphism and liver cancer risk. Tumor Biol. 2014;35(1):103–9.

    Article  CAS  Google Scholar 

  20. Jung KW, Ha E, Im Yu G, Kim SJ, Chung WJ, Jang BK, et al. TNFα promoter polymorphism is a risk factor for susceptibility in hepatocellular carcinoma in Korean population. Clin Chim Acta. 2009;407(1):16–9.

    Article  CAS  Google Scholar 

  21. Chen X, Zhang L, Chang Y, Shen T, Wang L, Zhuang H, et al. Association of TNF-alpha genetic polymorphisms with hepatocellular carcinoma susceptibility: a case-control study in a Han Chinese population. Int J Biol Markers. 2011;26(3):181–7.

    Article  CAS  Google Scholar 

  22. Feng H, Kuai J-H, Zhang M-Y, Wang G-C, Shi Y-J, Zhang J-Y. Tumor necrosis factor-alpha gene− 308G> A polymorphism alters the risk of hepatocellular carcinoma in a Han Chinese population. Diagn Pathol. 2014;9(1):199.

    Article  Google Scholar 

  23. Jeng J-S, Tsai J-F, Chuang L-Y, Ho M-S, Lin Z-Y, Hsieh M-Y, et al. Tumor necrosis factor-α 308.2 polymorphism is associated with advanced hepatic fibrosis and higher risk for hepatocellular carcinoma. Neoplasia. 2007;9(11):987–92.

    Article  CAS  Google Scholar 

  24. Yang Y, Qiu X-Q, Zeng X-Y, Bei C-H: Correlation of polymorphism of TNF-α gene promoter with susceptibility to hepatocellular carcinoma in Guangxi. China Oncology 2012, 12:3541.

  25. Akkız H, Bayram S, Bekar A, Özdil B, Akgöllü E, Sümbül AT, et al. G-308A TNF-α polymorphism is associated with an increased risk of hepatocellular carcinoma in the Turkish population: case-control study. Cancer Epidemiol. 2009;33(3):261–4.

    Article  Google Scholar 

  26. Hammer Ø, Harper D, Ryan P. Paleontological statistics software: package for education and data analysis. Palaeontol Electron. 2001;4

  27. Teixeira A, Mendes-Junior C, Marano L, Deghaide N, Secaf M, Elias-Junior J, et al. Alleles and genotypes of polymorphisms of IL-18, TNF-α and IFN-γ are associated with a higher risk and severity of hepatocellular carcinoma (HCC) in Brazil. Hum Immunol. 2013;74(8):1024–9.

    Article  CAS  Google Scholar 

  28. Sghaier I, Zidi S, Mouelhi L, Dabbech R, Ghazouani E, Brochot E, et al. The relationship between TNF alpha gene polymorphisms (− 238/− 308), TNF RII VNTR (p75) and outcomes of hepatitis B virus infection in Tunisian population. Gene. 2015;568(2):140–5.

    Article  CAS  Google Scholar 

  29. Li Y, Ou C, Shu H, Zhao H, Zhu B. The ERCC1-4533/8092, TNF-α 238/308 polymorphisms and the risk of hepatocellular carcinoma in Guangxi Zhuang populations of China: case-control study. Medicine. 2016;95(44):e5217.

    Article  CAS  Google Scholar 

  30. Panigrahi R, Sarkar N, Biswas A, Pal A, Saha D, Singh SP, et al. Association of TNF-α promoter polymorphism with HBV associated disease outcome among HBV infected patients from Orissa, southern part of East India. J Clin Exp Hepatol. 2014;4(3):202–8.

    Article  Google Scholar 

  31. Bruix J, Sherman M. Management of hepatocellular carcinoma: an update. Hepatology. 2011;53(3):1020–2.

    Article  Google Scholar 

  32. Wang B, Huang G, Wang D, Li A, Xu Z, Dong R, et al. Null genotypes of GSTM1 and GSTT1 contribute to hepatocellular carcinoma risk: evidence from an updated meta-analysis. J Hepatol. 2010;53(3):508–18.

    Article  Google Scholar 

  33. Azar SS, Mansoori M, Attar M, Shahbazi M. Tumor necrosis factor alpha 308 G/A single nucleotide polymorphism and susceptibility to hepatocellular carcinoma via hepatitis B infection. Asian Pac J Cancer Prev. 2016;17:3381–4.

    PubMed  Google Scholar 

  34. Verma I, Kaur J. Roli Saxena, Yogesh Kumar Chawla.

  35. Kew M. Epidemiology of chronic hepatitis B virus infection, hepatocellular carcinoma, and hepatitis B virus-induced hepatocellular carcinoma. Pathol Biol. 2010;58(4):273–7.

    Article  CAS  Google Scholar 

  36. Wang SS, Purdue MP, Cerhan JR, Zheng T, Menashe I, Armstrong BK, et al. Common gene variants in the tumor necrosis factor (TNF) and TNF receptor superfamilies and NF-kB transcription factors and non-Hodgkin lymphoma risk. PLoS One. 2009;4(4):e5360.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Faculty of Biological Science and Biotechnology, Shahid Beheshti University, Tehran, Iran

    Mehdi Heidari Horestani, Golnaz Atri Roozbahani & Masoud Sheidai

Authors
  1. Mehdi Heidari Horestani
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Golnaz Atri Roozbahani
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Masoud Sheidai
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Golnaz Atri Roozbahani.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Heidari Horestani, M., Atri Roozbahani, G. & Sheidai, M. The Potential Role of TNF-α (rs361525 and rs1800629) in Hepatocellular Carcinoma: Multivariate Analysis (Meta-Analysis). J Gastrointest Canc 50, 744–749 (2019). https://doi.org/10.1007/s12029-018-0135-y

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12029-018-0135-y

Keywords

Search

Navigation